News
Current position:Product Center > Antibodies > Biosimilar Antibodies > Anti-TA-MUC1(CD227)-DXD (Dar8)[DS-3939]
Anti-TA-MUC1(CD227)-DXD (Dar8)[DS-3939]
Product Info
Get A Quote

Cat.No:GM-87824AB

Product:Anti-TA-MUC1(CD227)-DXD (Dar8)[DS-3939]


Cat. No. & Size
Get A Quote

GM-87824AB-100       100μg

GM-87824AB-1mg      1mg



Description
Get A Quote

Expression System

CHO

Purity

> 95% as determined by SDS-PAGE

Aggregation

< 5% as determined by SEC-HPLC

Drug-to-Antibody Ratio (DAR)

8.0

Endotoxin

<1EU/mg

Sterility

0.22 μm Filtered

Target

CD227

Clone

DS-3939

Alternative Names

ADMCKD, ADMCKD1, ADTKD2, CA 15-3, CD227, Ca15-3, EMA, H23AG, KL-6, MAM6, MCD, MCKD, MCKD1, MUC-1, MUC-1/SEC, MUC-1/X/ZD, PEM, PEMT, PUM

Source/Isotype

Monoclonal Human IgG1, κ

Application

Positive control of Cytotoxicity Assay

Description

DS-3939 is an antibody-drug conjugate (ADC) candidate drug developed for targeted cancer therapy. It typically consists of a monoclonal antibody that specifically recognizes tumor-associated antigens, chemically linked to a cytotoxic payload. This type of drug aims to enhance antitumor activity and selectivity by precisely targeting tumor cells via the antibody, thereby reducing damage to normal cells.

Formulation

10 mM NaAc-HAc, pH5.0



Data
Get A Quote

image.png


image.png

image.png



Message Consultation
If you have more questions, please fill in the relevant information,we'll respond as soon as possible to assist you!
Reset
Submit
You can also contact us on the Scientist and Science Exchange marketplaces.
Current position:Product Center > -- > Anti-TA-MUC1(CD227)-DXD (Dar8)[DS-3939]
classify
Anti-TA-MUC1(CD227)-DXD (Dar8)[DS-3939]
Product Info
Get A Quote

Cat.No:GM-87824AB

Product:Anti-TA-MUC1(CD227)-DXD (Dar8)[DS-3939]


Cat. No. & Size
Get A Quote

GM-87824AB-100       100μg

GM-87824AB-1mg      1mg



Description
Get A Quote

Expression System

CHO

Purity

> 95% as determined by SDS-PAGE

Aggregation

< 5% as determined by SEC-HPLC

Drug-to-Antibody Ratio (DAR)

8.0

Endotoxin

<1EU/mg

Sterility

0.22 μm Filtered

Target

CD227

Clone

DS-3939

Alternative Names

ADMCKD, ADMCKD1, ADTKD2, CA 15-3, CD227, Ca15-3, EMA, H23AG, KL-6, MAM6, MCD, MCKD, MCKD1, MUC-1, MUC-1/SEC, MUC-1/X/ZD, PEM, PEMT, PUM

Source/Isotype

Monoclonal Human IgG1, κ

Application

Positive control of Cytotoxicity Assay

Description

DS-3939 is an antibody-drug conjugate (ADC) candidate drug developed for targeted cancer therapy. It typically consists of a monoclonal antibody that specifically recognizes tumor-associated antigens, chemically linked to a cytotoxic payload. This type of drug aims to enhance antitumor activity and selectivity by precisely targeting tumor cells via the antibody, thereby reducing damage to normal cells.

Formulation

10 mM NaAc-HAc, pH5.0



Data
Get A Quote

image.png


image.png

image.png



Message Consultation
If you have more questions, please fill in the relevant information,we'll respond as soon as possible to assist you!
Reset
Submit
You can also contact us on the Scientist and Science Exchange marketplaces.
Message consultation
reset
submit
Service
Message
Message consultation
reset
submit